We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSGE:NYSEMadison Square Garden Entertainment Corp. Analysis

Data as of 2026-07-06 - not real-time

$75.87

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Madison Square Garden Entertainment (MSGE) is trading at $75.87, just above its 20‑day SMA of $75.83 and comfortably above the 50‑day and 200‑day averages, indicating a short‑term bullish bias. The RSI sits at 53.6, suggesting neutral momentum, while the MACD histogram has turned slightly negative and the MACD line is below its signal, hinting at a potential near‑term pullback. Volume is on an upward trend, supporting the price advance, and the technical support level at $69.44 provides a cushion against downside risk. Fundamentally, the company’s forward PE of 30× and a DCF‑derived fair value of $79.76 imply only a modest 3% upside, yet the trailing PE of 73.7× and a price‑to‑book of 74.7× signal severe overvaluation relative to earnings and book value. Profitability is thin, with a profit margin of 4.8% and ROE of just 1.7%, while a debt‑to‑equity ratio above 2,400% underscores a heavy leverage burden. Recent news of the New York Knicks’ championship and an Ariel Investments “top stock to buy” endorsement could spur short‑term demand for venue events, but the company’s low dividend yield, high debt load, and modest revenue growth (1.6%) temper enthusiasm for long‑term appreciation.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Technical price above short‑term moving averages
  • Increasing volume and recent positive event‑related news
  • Modest DCF upside despite high valuation multiples

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS growth expectations
  • Potential boost to venue bookings from heightened sports enthusiasm
  • Improving cash flow generation relative to debt service

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent high leverage and weak ROE
  • Valuation still far above industry peers
  • Cyclical exposure of entertainment demand to economic conditions

Key Metrics & Analysis

Financial Health

Revenue Growth1.60%
Profit Margin4.81%
P/E Ratio73.7
ROE170.32%
ROA5.02%
Debt/Equity2473.06
P/B Ratio74.7
Op. Cash Flow$341.0M
Free Cash Flow$328.7M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI53.6
Support$69.44
Resistance$82.79
MA 20$75.83
MA 50$70.95
MA 200$58.01
MACDBearish
VolumeIncreasing
Fear & Greed Index93.63

Valuation

Fair Value$79.76
Target Price$78.14
Upside/Downside3.00%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.79
Volatility24.09%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.